TABLE OF CONTENTS

1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET DEFINITION 9
1.3 OVERVIEW OF SWITZERLAND MEDICAL AESTHETICS MARKET 10
1.4 CURRENCY AND PRICING 11
1.5 LIMITATIONS 11
1.6 MARKETS COVERED 11
2 MARKET SEGMENTATION 13
2.1 MARKETS COVERED 13
2.2 GEOGRAPHIC SCOPE 14
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 RESEARCH METHODOLOGY 16
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
2.7 SECONDARY SOURCES 20
2.8 ASSUMPTIONS 20
3 MARKET OVERVIEW 21
3.1 DRIVERS 23
3.1.1 GROWING AGING POPULATION 23
3.1.2 TECHNOLOGICAL ADVANCEMENTS 23
3.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE 24
3.2 RESTRAINTS 25
3.2.1 REGULATORY SCENARIO 25
3.2.2 HIGH COST OF TREATMENT 25
3.3 OPPORTUNITIES 26
3.3.1 IMMINENT HEALTH REVOLUTION 26
3.3.2 GROWING MEDICAL TOURISM 26
3.4 CHALLENGE 27
3.4.1 INCREASING COMPETITORS 27
4 EXECUTIVE SUMMARY 28
5 PREMIUM INSIGHTS 30
6 SWITZERLAND MEDICAL AESTHETICS MARKET: REGULATORY SCENARIO 31
6.1 OVERVIEW 31
6.1.1 FDA REGULATORY PROCEDURE 31
6.1.2 SWISS APPROVAL INTERNATIONAL 33
7 SWITZERLAND MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE 34
7.1 OVERVIEW 35
7.2 ENERGY DEVICES 36
7.2.1 ELECTROCAUTERY DEVICES 37
7.2.2 ELECTROSURGERY DEVICES 37
7.2.3 CRYOSURGERY DEVICES 38
7.2.4 LASER SURGERY DEVICES 38
7.2.5 MICROWAVE DEVICES 38
7.2.6 HARMONIC SCALPEL 39
7.3 AESTHETIC LASER DEVICES 39
7.3.1 CARBON DIOXIDE LASER SURFACING 40
7.3.2 ABLATIVE SKIN RESURFACING DEVICES 40
7.3.3 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES 40
7.4 AESTHETIC IMPLANTS 41
7.4.1 BREAST AUGMENTATION 41
7.4.2 AESTHETIC DENTAL IMPLANTS 42
7.4.3 SOFT TISSUE IMPLANT 42
7.4.4 BUTTOCK AUGMENTATION 42
7.4.5 TRANSDERMAL IMPLANT 43
7.5 SKIN TIGHTENING AND BODY CONTOURING DEVICES 43
7.5.1 LIPOSUCTION DEVICES 44
7.5.2 CELLULITE REDUCTION DEVICES 44
7.5.3 SKIN TIGHTENING DEVICES 44
7.6 FACIAL AESTHETIC DEVICES 45
7.6.1 BOTOX INJECTION 46
7.6.2 CHEMICAL PEELS 46
7.6.3 COLLAGEN INJECTIONS 46
7.6.4 COSMETIC ACUPUNCTURE 47
7.6.5 DERMAL FILLER INJECTIONS 47
7.6.6 ELECTROTHERAPY 47
7.6.7 FACIAL TONING 48
7.6.8 FRAXEL 48
7.6.9 MICRODERMABRASION 48
7.6.10 PERMANENT MAKEUP 49
8 SWITZERLAND MEDICAL AESTHETICS MARKET, BY APPLICATION 50
8.1 OVERVIEW 51
8.2 ANTI-AGING AND WRINKLES 52
8.3 FACIAL AND SKIN REJUVENATION 53
8.4 VASCULAR LESIONS 53
8.5 BODY SHAPING AND CELLULITE 53
8.6 BREAST ENHANCEMENT 54
8.7 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE 54
8.8 TATTOO REMOVAL 54
8.9 PSORIASIS AND VITILIGO 55
9 SWITZERLAND MEDICAL AESTHETICS MARKET, BY END USER 56
9.1 OVERVIEW 57
9.2 DERMATOLOGY CLINICS 58
9.3 COSMETIC CENTERS 58
9.4 HOSPITALS 58
9.5 MEDICAL SPAS AND BEAUTY CENTERS 59
10 SWITZERLAND MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL 60
10.1 OVERVIEW 61
10.2 DIRECT TENDER 62
10.3 RETAIL 62
11 SWITZERLAND MEDICAL AESTHETIC MARKET, COMPANY LANDSCAPE 63
11.1 COMPANY SHARE ANALYSIS: SWITZERLAND 63
12 COMPANY PROFILES 64
12.1 ALLERGAN 64
12.1.1 COMPANY OVERVIEW 64
12.1.2 REVENUE ANALYSIS 64
12.1.3 PRODUCT PORTFOLIO 65
12.1.4 RECENT DEVELOPMENTS 65
12.2 LUMENIS 67
12.2.1 COMPANY OVERVIEW 67
12.2.2 COMPANY SNAPSHOT 67
12.2.3 PRODUCT PORTFOLIO 68
12.2.4 RECENT DEVELOPMENTS 68
12.3 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD. 69
12.3.1 COMPANY OVERVIEW 69
12.3.2 REVENUE ANALYSIS 69
12.3.3 PRODUCT PORTFOLIO 70
12.3.4 RECENT DEVELOPMENTS 70
12.4 SYNERON MEDICAL LTD. 71
12.4.1 COMPANY OVERVIEW 71
12.4.2 REVENUE ANALYSIS 71
12.4.3 PRODUCT PORTFOLIO 72
12.4.4 RECENT DEVELOPMENTS 72
12.5 BTL 73
12.5.1 COMPANY OVERVIEW 73
12.5.2 COMPANY SNAPSHOT 73
12.5.3 PRODUCT PORTFOLIO 74
12.5.4 RECENT DEVELOPMENT 74
12.6 CUTERA, INC. 75
12.6.1 COMPANY OVERVIEW 75
12.6.2 REVENUE ANALYSIS 75
12.6.3 PRODUCT PORTFOLIO 76
12.6.4 RECENT DEVELOPMENTS 76
12.7 LUTRONIC 77
12.7.1 COMPANY OVERVIEW 77
12.7.2 COMPANY SNAPSHOT 77
12.7.3 PRODUCT DEVELOPMENT 78
12.7.4 RECENT DEVELOPMENTS 78
12.8 QUANTA AESTHETICS LASERS 79
12.8.1 COMPANY OVERVIEW 79
12.8.2 COMPANY SNAPSHOT 79
12.8.3 PRODUCT PORTFOLIO 79
12.8.4 RECENT DEVELOPMENTS 79
12.9 SCITON, INC. 80
12.9.1 COMPANY OVERVIEW 80
12.9.2 COMPANY SNAPSHOT 80
12.9.3 PRODUCT PORTFOLIO 81
12.9.4 RECENT DEVELOPMENTS 81
13 RELATED REPORTS 82
?